Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TX › Dallas › NPI 1669991097
Physician

Kai Medical Laboratories, LLC

Kai Medical Laboratories, LLC was paid $13K by Medicaid between Jul 2019 and Apr 2021, across 33 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 69% of everything it billed.

33Billing provider infoKAI MEDICAL LABORATORIES, LLC
DALLAS, TX 75247
33aNPI1669991097assigned 09/18/2017
28Total paid$13K
24GClaims1,500
24DCodes billed33
24AFirst – last monthJul 2019 – Apr 2021
Compared with peers

Next to other Clinical Pathology/Laboratory Medicine Physician providers in Texas

Rank by total paid#9 of 10
Median peer was paid$116K
This provider vs. median0.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$2.0K$4.0K$6.0K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20191,220$1K
2020205$7K
202175$4K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 69% 125 110 $9K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 18% 244 177 $2K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 12% 241 177 $2K
83498 0% 35 35 $0.00
84410 0% 21 21 $0.00
80053 Comprehensive metabolic panel 0% 13 13 $0.00
82670 0% 35 35 $0.00
83002 0% 35 35 $0.00
84480 0% 35 35 $0.00
84270 0% 49 35 $0.00
82040 0% 34 34 $0.00
82150 0% 13 13 $0.00
21 more codes
84144 0% 35 $0.00
83090 0% 35 $0.00
83036 Hemoglobin; glycosylated (A1C) 0% 17 $0.00
82607 0% 36 $0.00
83001 0% 35 $0.00
83735 0% 13 $0.00
82746 0% 35 $0.00
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 0% 35 $0.00
82533 0% 35 $0.00
84443 Thyroid stimulating hormone (TSH) 0% 35 $0.00
84481 0% 26 $0.00
82088 0% 35 $0.00
83003 0% 35 $0.00
84403 0% 35 $0.00
82248 0% 13 $0.00
84100 0% 13 $0.00
82627 0% 35 $0.00
82157 0% 35 $0.00
84439 0% 35 $0.00
80061 Lipid panel 0% 12 $0.00
82652 0% 35 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialTYLER, YOSHI (PRESIDENT)